Dermatology

Topical non-prescription products can provide relief from dermatitis.

A new study finds that patients with autoimmune diseases being treated with immunosuppressive drugs are not at an increased risk of developing shingles.

New efficacy and safety data from the Phase 3 PHOENIX 1 study, 1 of 2 pivotal registration trials, showed that maintenance treatment with Stelara (ustekinumab) for up to 5 years resulted in consistent, significant clinical response in adults with moderate to severe plaque psoriasis.

Patients with psoriasis need assistance balancing a complicated treatment plan can include phototherapy, topical medications, systemic agents, and biological treatments.